On Thursday shares of VIVUS Inc. (NASDAQ:VVUS) closed at $2.50. Company’s sales growth for last 5 years was 29.50% and EPS growth for next 5 years is recorded as 6.70%. On April 21, VIVUS, Inc.(NASDAQ: VVUS) , announced that the United States Patent and Trademark Office has issued U.S. Patent Nos. 9,011,905 , covering compositions of Qsymia, and 9,011,906 , covering methods for effecting weight loss using Qsymia.
Cliffs Natural Resources Inc. (NYSE:CLF) in last trading activity advanced 9.45% to close at $5.56. Company weekly performance is 0.91% while its quarterly performance stands at -35.27%. Cliffs Natural Resources Inc. (NYSE:CLF) is -69.53% away from its 52 week high. Equities research analysts at RBC Capital lowered their price objective on shares of Cliffs Natural Resources (NYSE:CLF) from $7.50 to $6.00 in a research note issued to investors on Thursday. The firm currently has a “sector perform” rating on the stock.
On last trading day Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) advanced 2.90% to close at $68.90. Its volatility for the week is 5.68% while volatility for the month is 6.01%. Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) monthly performance is 18.04%. Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), announced the presentation of positive data from an investigator-sponsored trial of triheptanoin (UX007) for the treatment of movement disorders associated with glucose transporter type-1 deficiency syndrome (Glut1 DS).
On Thursday shares of Altera Corp. (NASDAQ:ALTR) closed at $42.09. Company’s sales growth for last 5 years was 10.10% and EPS growth for next 5 years is recorded as 11.38%. Altera Corp. (ALTR: Quote) profit for the first quarter declined from last year and results missed analysts’ expectations. The company also gave a revenue outlook for the second quarter below Street estimates. Net sales for the quarter declined 6 percent to $435.49 million from $461.09 million in the same quarter last year, and missed analysts’ consensus estimate of $471.00 million.
On last trading day Arctic Cat Inc. (NASDAQ:ACAT) advanced 1.15% to close at $37.06. Its volatility for the week is 3.09% while volatility for the month is 3.16%. ACAT’s sales growth for past 5 years was 5.30% and its EPS growth for past 5 years was 49.50%. Arctic Cat Inc. (NASDAQ:ACAT) monthly performance is -2.63%. On April 23, Arctic Cat Inc. (NASDAQ:ACAT) announced two strategic hires into newly created roles and a promotion, as the company builds its sales and marketing capabilities for the future under new president and CEO, Chris Metz. Effective immediately, Greg Williamson joins Arctic Cat as its first-ever chief marketing officer, while Brit Reich joins as vice president of North America sales. Mike Webster has been promoted to director of North America sales.